These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Heterogeneity in RAG1 and RAG2 deficiency: 35 cases from a single-centre. Karaatmaca B; Cagdas D; Esenboga S; Erman B; Tan C; Turul Ozgur T; Boztug K; van der Burg M; Sanal O; Tezcan I Clin Exp Immunol; 2024 Feb; 215(2):160-176. PubMed ID: 37724703 [TBL] [Abstract][Full Text] [Related]
6. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V Front Immunol; 2023; 14():1268620. PubMed ID: 38022635 [TBL] [Abstract][Full Text] [Related]
7. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes. IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478 [TBL] [Abstract][Full Text] [Related]
8. Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency. Delmonte OM; Villa A; Notarangelo LD Blood; 2020 Feb; 135(9):610-619. PubMed ID: 31942628 [TBL] [Abstract][Full Text] [Related]
9. Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency. John T; Walter JE; Schuetz C; Chen K; Abraham RS; Bonfim C; Boyce TG; Joshi AY; Kang E; Carvalho BT; Mahajerin A; Nugent D; Puthenveetil G; Soni A; Su H; Cowan MJ; Notarangelo L; Buchbinder D J Clin Immunol; 2016 Oct; 36(7):725-32. PubMed ID: 27539235 [TBL] [Abstract][Full Text] [Related]
10. Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency. Geier CB; Farmer JR; Foldvari Z; Ujhazi B; Steininger J; Sleasman JW; Parikh S; Dilley MA; Pai SY; Henderson L; Hazen M; Neven B; Moshous D; Sharapova SO; Mihailova S; Yankova P; Naumova E; Özen S; Byram K; Fernandez J; Wolf HM; Eibl MM; Notarangelo LD; Calabrese LH; Walter JE Front Immunol; 2020; 11():574738. PubMed ID: 33193364 [TBL] [Abstract][Full Text] [Related]
11. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis. Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659 [TBL] [Abstract][Full Text] [Related]
12. Approaches to patients with variants in RAG genes: from diagnosis to timely treatment. Bulkhi AA; Dasso JF; Schuetz C; Walter JE Expert Rev Clin Immunol; 2019 Oct; 15(10):1033-1046. PubMed ID: 31535575 [No Abstract] [Full Text] [Related]
13. Human RAG mutations: biochemistry and clinical implications. Notarangelo LD; Kim MS; Walter JE; Lee YN Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199 [TBL] [Abstract][Full Text] [Related]